 "Quick Heal IPO oversubscribed 1.81 times")
The initial public offer (IPO) of software provider Quick Heal Technologies has been oversubscribed 1.81 times till afternoon on the last day of the offer today.
The Rs 451-crore IPO received bids for 1.83 crore shares against the total issue size of over 1 crore shares, data available with the NSE till 1300 hrs showed.
Quick Heal has already raised Rs 133.9 crore through issue of shares to 10 anchor investors.
The company has fixed the price band at Rs 311-321 for its IPO.
The IPO, which would close today, consists of fresh issue of Rs 250 crore and an offer for sale of about 62.70 lakh equity shares by promoters Kailash Sahebrao Katkar and Sanjay Sahebrao Katkar, as well as Sequoia Capital India Investment Holdings III.
ICICI Securities, Jefferies India and JPMorgan India are the book running lead managers while Link Intime India is the registrar to the public issue.
While the proceeds from the offer of sale would not go to Quick Heal Technologies, the Rs 250-crore funds raised from fresh issue of equity shares would be used by the company for advertising and sales promotion and capital expenditure for research and development.
The proceeds would also be invested to purchase, develop and renovate its office premises in Kolkata, Pune and New Delhi, as well as general corporate needs.
The company is a provider of security software products and solutions in India.
Quick Heal's equity shares are proposed to be listed on BSE and NSE.
The Rs 451-crore IPO received bids for 1.83 crore shares against the total issue size of over 1 crore shares, data available with the NSE till 1300 hrs showed.
Quick Heal has already raised Rs 133.9 crore through issue of shares to 10 anchor investors.
The company has fixed the price band at Rs 311-321 for its IPO.
ALSO READ: Quick Heal IPO subscribed 77%
The IPO, which would close today, consists of fresh issue of Rs 250 crore and an offer for sale of about 62.70 lakh equity shares by promoters Kailash Sahebrao Katkar and Sanjay Sahebrao Katkar, as well as Sequoia Capital India Investment Holdings III.
ICICI Securities, Jefferies India and JPMorgan India are the book running lead managers while Link Intime India is the registrar to the public issue.
While the proceeds from the offer of sale would not go to Quick Heal Technologies, the Rs 250-crore funds raised from fresh issue of equity shares would be used by the company for advertising and sales promotion and capital expenditure for research and development.
The proceeds would also be invested to purchase, develop and renovate its office premises in Kolkata, Pune and New Delhi, as well as general corporate needs.
The company is a provider of security software products and solutions in India.
Quick Heal's equity shares are proposed to be listed on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%